Horizon Therapeutics (HZNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Sales | 1,056,231 | 981,120 | 757,044 | 296,955 | 74,016 |
| Cost of Goods | 493,368 | 392,001 | 219,502 | 78,753 | 14,625 |
| Gross Profit | 562,863 | 589,119 | 537,542 | 218,202 | 59,391 |
| Operating Expenses | 902,693 | 735,016 | 482,672 | 227,446 | 102,870 |
| Operating Income | -339,462 | -145,896 | 55,372 | -8,491 | -42,854 |
| Interest Expense | 126,523 | 86,610 | 69,900 | 23,826 | 12,774 |
| Other Income | 7,174 | 5,692 | -118,184 | -237,370 | -94,498 |
| Pre-tax Income | -458,811 | -226,814 | -132,712 | -269,687 | -150,126 |
| Income Tax | -108,686 | -61,251 | -172,244 | -6,084 | -1,121 |
| Net Income Continuous | -350,125 | -165,563 | 39,532 | -263,603 | -149,005 |
| Net Income | $-350,125 | $-165,563 | $39,532 | $-263,603 | $-149,005 |
| EPS Basic Total Ops | -2.15 | -1.03 | 0.27 | -3.15 | -2.34 |
| EPS Basic Continuous Ops | -2.15 | -1.03 | 0.27 | -3.15 | -2.34 |
| EPS Diluted Total Ops | -2.15 | -1.03 | 0.25 | -3.15 | -2.34 |
| EPS Diluted Continuous Ops | -2.15 | -1.03 | 0.25 | -3.15 | -2.34 |
| EPS Diluted Before Non-Recurring Items | 1.18 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-61,756 | $165,575 | $212,525 | $34,791 | $-29,180 |